# ASPIRIN; OMEPRAZOLE
> **ANDA209791** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-01-20
## Drug
- **FDA Application Number:** ANDA209791
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ASPIRIN; OMEPRAZOLE
- **Generic name:** Aspirin
- **Active ingredients:** ASPIRIN; OMEPRAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2023-01-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209791)
---
*MORVS · CC0 1.0*